Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Cormio, Antonella ^a   Guerra, Flora ^a,b   Cormio, Gennaro ^b   Pesce, Vito ^a   Fracasso, Flavio ^a   Loizzi, Vera ^b   Resta, Leonardo ^a   Putignano, Giuseppe ^a   Cantatore, Palmiro ^a,c   Selvaggi, Luigi Eustacchio ^b   Gadaleta, Maria Nicola ^a,c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c CNR   (Italy)

Author keywords

Atypical hyperplasia; Citrate synthase activity; Endometrial cancer; MtDNA content; Typical hyperplasia

Indexed keywords

CITRATE SYNTHASE; MITOCHONDRIAL DNA;

ARTICLE; DISEASE COURSE; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; ENZYMOLOGY; FEMALE; HUMAN; METABOLISM; ORGAN SIZE; PATHOLOGY;

CITRATE (SI)-SYNTHASE; DISEASE PROGRESSION; DNA, MITOCHONDRIAL; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; ORGAN SIZE;

EID: 84861849683     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-279     Document Type: Article

References (25)

1. Two pathogenetic types of endometrial carcinoma. Bokhman JV, Gynecol Oncol 1983 15 10 17 10.1016/0090-8258(83)90111-7 6822361
2. Endometrial hyperplasia: a review. Montgomery BE, Daum GS, Dunton CJ, Obstet Gynecol Surv 2004 59 368 378 10.1097/00006254-200405000-00025 15097798
3. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. Linkov F, Edwards R, Balk J, Yurkovetsky Z, Stadterman B, Lokshin A, Taioli E, Eur J Cancer 2008 12 1632 1644
4. Endometrial hyperplasia and the risk of progression to carcinoma. Lacey JV Jr, Chia VM, Maturitas 2009 63 39 44 10.1016/j.maturitas.2009.02.005 19285814
5. On respiratory impairment in cancer cells. Warburg O, Science 1956 124 269 270 13351639
6. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Scarpulla RC, Physiol Rev 2008 88 611 638 10.1152/physrev.00025.2007 18391175
7. Mitochondrial DNA depletion reduces PARP-1 levels and promotes progression of the neoplastic phenotype in prostate carcinoma. Moro L, Arbini AA, Marra E, Greco M, Cell Oncol 2008 30 307 322 18607066
8. Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. Yu M, Zhou Y, Shi Y, Ning L, Yang Y, Wei X, Zhang N, Hao X, Niu R, IUBMB Life 2007 59 450 457 10.1080/15216540701509955 17654121
9. Association of decreased mitochondrial DNA content with ovarian cancer progression. Wang Y, Liu VW, Xue WC, Cheung AN, Ngan HY, Br J Cancer 2006 95 1087 1091 10.1038/sj.bjc.6603377 17047655
10. Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells. Mizumachi T, Muskhelishvili L, Naito A, Furusawa J, Fan CY, Siegel ER, Kadlubar FF, Kumar U, Higuchi M, Prostate 2008 68 408 417 10.1002/pros.20697 18196528
11. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Wang Y, Liu VW, Xue WC, Tsang PC, Cheung AN, Ngan HY, Gynecol Oncol 2005 98 104 110 10.1016/j.ygyno.2005.04.015 15921730
12. Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. Jones JB, Song JJ, Hempen PM, Parmigiani G, Hruban RH, Kern SE, Cancer Res 2001 61 1299 1304 11245424
13. PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma. Savagner F, Mirebeau D, Jacques C, Guyetant S, Morgan C, Franc B, Reynier P, Malthièry Y, Biochem Biophys Res Commun 2003 310 779 784 10.1016/j.bbrc.2003.09.076 14550271
14. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Gasparre G, Hervouet E, de Laplanche E, Demont J, Pennisi LF, Colombel M, Mège-Lechevallier F, Scoazec JY, Bonora E, Smeets R, Smeitink J, Lazar V, Lespinasse J, Giraud S, Godinot C, Romeo G, Simonnet H, Hum Mol Genet 2008 17 986 995 18156159
15. The PGC-1alpha-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer. Cormio A, Guerra F, Cormio G, Pesce V, Fracasso F, Loizzi V, Cantatore P, Selvaggi L, Gadaleta MN, Biochem Biophys Res Commun 2009 390 1182 1185 10.1016/j.bbrc.2009.10.114 19861117
16. Increased mitochondrial mass in mitochondrial myopathy mice. Wredenberg A, Wibom R, Wilhelmsson H, Graff C, Wiener HH, Burden SJ, Oldfors A, Westerblad H, Larsson NG, Proc Natl Acad Sci USA 2002 99 15066 15071 10.1073/pnas.232591499 12417746
17. Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma. Guerra F, Kurelac I, Cormio A, et al. Hum Mol Genet 2011 20 2394 2405 10.1093/hmg/ddr146 21470976
18. Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium. Sarmadi S, Izadi-Mood N, Sotoudeh K, Tavangar SM, Diagn Pathol 2009 4 41 10.1186/1746-1596-4-41 19930726
19. Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium. Kokawa K, Shikone T, Otani T, Nishiyama R, Ishii Y, Yagi S, Yamoto M, Hum Reprod 2001 10 2211 2218
20. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues. Pervez S, Hitchcock A, Sinton TM, Mani A, Smith JL, Pathol Res Pract 2002 198 13 17 10.1078/0344-0338-00178 11866205
21. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Chen JQ, Cammarata PR, Baines CP, Yager JD, Biochim Biophys Acta 2009 1793 1540 1470 10.1016/j.bbamcr.2009.06.001 19559056
22. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mattingly KA, Ivanova MM, Riggs KA, Wickramasinghe NS, Barch MJ, Klinge CM, Mol Endocrinol 2008 22 609 622 18048642
23. Estrogen induced mitochondrial reactive oxygen species as signal-transducing messengers. Felty Q, Xiong WC, Sun D, Sarkar S, Singh KP, Parkash J, Roy D, Biochemistry 2005 44 6900 6909 10.1021/bi047629p 15865435
24. Superoxide dismutase and lipid hydroperoxides in blood and endometrial tissue of patients with benign, hyperplastic and malignant endometrium. Pejić S, Todorović A, Stojiljković V, Cvetković D, Lucić N, Radojicić RM, Saicić ZS, Pajović SB, An Acad Bras Cienc 2008 80 515 522 18797802
25. FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Zaino RJ, Int J Gynecol Pathol 2009 28 1 9 10.1097/PGP. 0b013e3181846c6d 19047915